A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies
about
A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
A reliable and feasible way to ...... is of 14 retrospective studies
@en
A reliable and feasible way to ...... is of 14 retrospective studies
@nl
type
label
A reliable and feasible way to ...... is of 14 retrospective studies
@en
A reliable and feasible way to ...... is of 14 retrospective studies
@nl
prefLabel
A reliable and feasible way to ...... is of 14 retrospective studies
@en
A reliable and feasible way to ...... is of 14 retrospective studies
@nl
P2093
P2860
P1433
P1476
A reliable and feasible way to ...... is of 14 retrospective studies
@en
P2093
P2860
P304
P356
10.1080/2162402X.2018.1507262
P407
P577
2018-01-01T00:00:00Z